Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Standard BioTools: Q4 Earnings Snapshot
Standard BioTools: Q4 Earnings Snapshot
Associated Press Finance
Wed, February 25, 2026 at 6:34 AM GMT+9 1 min read
In this article:
LAB
+3.60%
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Standard BioTools Inc. (LAB) on Tuesday reported earnings of $19.3 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had net income of 5 cents. Earnings, adjusted for one-time gains and costs, came to 6 cents per share.
The company that makes equipment to control fluids posted revenue of $23.8 million in the period.
For the year, the company reported a loss of $74.9 million, or 20 cents per share. Revenue was reported as $85.3 million.
Standard BioTools expects full-year revenue in the range of $80 million to $85 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on LAB at
Terms and Privacy Policy
Privacy Dashboard
More Info